| American Heart Association Late Breaking Clinical Trial... |
|
|
Study highlights: In patients with or at high-risk for coronary artery disease and LDL (bad cholesterol) treated with statins to < 100mg/dL but low HDL (good cholesterol),... More »
|
|
Houston Chronicle - Nov. 15, 2009
|
| Merck, Abbott Rise After Study |
|
Shares of pharmaceutical company Merck (MRK) rose 2% Monday following a study of cholesterol drug Zetia that showed Zetia did not combat artery clogging as well as Niaspan,... More »
|
|
FOXNews.com - Nov. 16, 2009
|
| Doctors Gird for Patient Anxiety Over Zetia Data |
|
ORLANDO, Florida (Reuters) - The good news for Merck & Co's Zetia cholesterol fighter is that doctors do not seem unduly concerned about its latest setback in a clinical... More »
|
|
ABC News - Nov. 16, 2009
|
| Cheap Vitamin B Best for Clearing Arteries? |
|
So said Dr. Anthony DeMaria, a leading cardiologist who is also the editor in chief of the Journal of the American College of Cardiology. He was referring to the results of a... More »
|
|
ABC News - Nov. 16, 2009
|
| Niacin Tops Zetia in Cutting Artery Plaque |
|
Nov. 16, 2009 (Orlando, Fla.) -- A prescription version of niacin beat out a blockbuster cholesterol-lowering drug in slowing the buildup of plaque in artery walls,... More »
|
|
WebMD - Nov. 16, 2009
|
| Cholesterol drug concerns |
|
A study raises fresh concerns about Zetia and Vytorin. CNN's Elizabeth Cohen reports. More »
|
|
CNN - Nov. 16, 2009
|
| Early end to key study on benefits of niacin, a B vitamin,... |
|
Heart experts at Johns Hopkins are calling premature the early halt of a study by researchers at Walter Reed Army Medical Center and Washington Hospital Center on the... More »
|
|
Genetic Engineering News - Nov. 16, 2009
|
| New Study Raises New Questions About Cholesterol Drug Zetia |
|
By Amanda Gardner HealthDay Reporter SUNDAY, Nov. 15 (HealthDay News) -- A new study raises more questions about ezetimibe (Zetia), a drug used by millions of Americans in... More »
|
|
US News - Nov. 16, 2009
|
| Study Raises New Questions About Cholesterol Drugs |
|
A new study raises fresh concerns about Zetia and its cousin, Vytorin — drugs still taken by millions of Americans to lower cholesterol, despite questions raised last year... More »
|
|
FOXNews.com - Nov. 16, 2009
|
| Study Raises Questions About Cholesterol Drug’s Benefit |
|
ORLANDO, Fla. For patients taking a statin to control high cholesterol, adding an old standby drug, niacin, was superior in reducing buildup in the carotid artery to adding... More »
|
|
- Nov. 15, 2009
|
|
Images
|
|
Study Raises Questions About 2 Cholesterol Drugs
CBS
|
Study raises concerns about Merck's Zetia
NBC
|